NSC59984 is primarily investigated for its potential in cancer research, particularly in cancers associated with p53 gene mutations, which play a key role in regulating the cell cycle. It has shown promise in reactivating the function of mutant p53, thereby targeting and inhibiting specific pathways involved in tumor growth and progression. Researchers are exploring its efficacy in inducing apoptosis in cancer cells, especially in cases where traditional therapies have failed. Additionally, it is being studied for its role in enhancing the effectiveness of other anticancer agents, such as in combination with chemotherapy, particularly against drug-resistant cancer cells. Its application extends to preclinical studies aiming to understand its mechanism of action and potential therapeutic benefits in various cancer types. However, its use remains in the experimental stage, requiring further studies to confirm safety and clinical efficacy.